Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 59 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/13
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 02/28/05
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 05/24/21
End: 08/31/27
Due: 08/31/28
Phase: N/A
Priority: Normal
Start: 05/10/23
End: 08/31/35
Due: 08/31/36
Phase: N/A
Priority: Normal
Start: 03/22/23
End: 12/26/26
Due: 12/26/27
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 12/28/15
End: 05/02/24
Due: 05/02/25
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 11/30/00
Due: 11/30/01
Phase: N/A
Priority: Normal
Start: 11/06/18
End: 03/01/20
Due: 03/01/21
Phase: N/A
Priority: Normal
Start: 07/31/00
End: 07/31/03
Due: 07/31/04
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 07/31/16
Due: 07/31/17
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Phase: N/A
Priority: Normal
Start: 07/25/23
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 09/21/18
End: 06/17/26
Due: 06/17/27
Phase: N/A
Priority: Normal
Start: 02/16/21
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 09/15/25
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 10/10/18
End: 06/13/20
Due: 06/13/21
Phase: N/A
Priority: Normal
Start: 10/11/16
End: 02/03/23
Due: 02/03/24
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 03/21/26
Due: 03/21/27
Phase: N/A
Priority: Normal
Start: 05/31/22
End: 01/31/25
Due: 01/31/26
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 08/01/29
Due: 08/01/30
Phase: N/A
Priority: Normal
Start: 05/03/24
End: 01/31/27
Due: 01/31/28
Phase: N/A
Priority: Normal
Start: 04/26/21
End: 01/02/26
Due: 01/02/27
Phase: N/A
Priority: Normal
Start: 11/30/00
End: 04/30/06
Due: 04/30/07
Phase: N/A
Priority: Normal
Start: 05/14/08
End: 04/19/17
Due: 04/19/18